FREDDIE DAYAO: Open Payments
NPI 1447967559 · NEW HAVEN, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,959 in 76 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $125 · 2025 $1,959
Food & beverage: $1,959
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 14 | $510 |
| ABBVIE INC. | 18 | $387 |
| GlaxoSmithKline, LLC. | 4 | $198 |
| Indivior Inc. | 8 | $189 |
| Orexo US, Inc. | 11 | $149 |
| Braeburn Inc. | 5 | $132 |
| Alkermes, Inc. | 4 | $90 |
| ANI Pharmaceuticals, Inc. | 3 | $82 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $54 |
| Exact Sciences Corporation | 1 | $33 |
Products named: AIRSUPRA, SUBLOCADE, QULIPTA, BREZTRI, Zubsolv, BRIXADI, FARXIGA, VRAYLAR.
Industry payments across CT — which companies pay providers there.
